Experiment 638234

Details

PropertyValue
Pharmacology
Administration routeROUTE NOT GIVEN
OrganismEmpty organism
CitationKIDD,PM:. (1999). A REVIEW OF NUTRIENTS AND BOTANICALS IN THE INTEGRATIVE MANAGEMENT OF COGNITIVE DYSFUNCTION.. 4(3)
Amount utilized
Compound isolated
DiseaseVINPOCETINE MAY HAVE CLINICAL UTILITY IN THE MANAGEMENT OF STROKE SEQUELAE, AS SUGGESTED BY AN OPEN-LABEL TRIAL CONDUCTED AT 40 CENTERS IN JAPAN. THE TREATMENT DESIGN INVOLVED CROSSOVER EVERY FOUR WEEKS BETWEEN VINPOCETINE, IFENPRODIL TARTRATE, AND DIHYDROERGOTOXINE MESYLATE. ADMINISTERED AT 15 MG PER DAY, VINPOCETINE PRODUCED SLIGHT-TO-MARKED IMPROVEMENT IN TWO-THIRDS OF THE PATIENTS, WHICH WAS SUPERIOR TO THE OTHER TWO AGENTS TESTED.
Dose amount15.0 MG
Number4
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES